Literature DB >> 21393233

Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients.

Raquel Inocêncio da Luz, Gustavo A S Romero, Maria Elizabeth Dorval, Israel Cruz, Carmen Cañavate, Jean-Claude Dujardin, Tim Van Assche, Paul Cos, Louis Maes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21393233     DOI： 10.1093/jac/dkq508

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.

Authors:  S Hendrickx; A Mondelaers; E Eberhardt; L Lachaud; P Delputte; P Cos; L Maes
Journal:  Parasitol Res       Date:  2015-04-17       Impact factor: 2.289

2.  Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.

Authors:  Denis Sereno; Carla Maia; Khatima Aït-Oudhia
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

3.  Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.

Authors:  Joana Cunha; Eugenia Carrillo; Carmen Sánchez; Israel Cruz; Javier Moreno; Anabela Cordeiro-da-Silva
Journal:  Parasit Vectors       Date:  2013-04-26       Impact factor: 3.876

Review 4.  Visceral leishmaniasis and HIV coinfection in Latin America.

Authors:  José Angelo Lindoso; Gláucia Fernandes Cota; Alda Maria da Cruz; Hiro Goto; Ana Nilce Silveira Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Márcia Leite de Sousa-Gomes; Joanna Reis Santos-Oliveira; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

5.  Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil.

Authors:  Lucas S Magalhães; Lays Gs Bomfim; Sthefanne G Mota; Geydson S Cruz; Cristiane B Corrêa; Diego M Tanajura; Michael W Lipscomb; Valéria M Borges; Amélia R de Jesus; Roque P de Almeida; Tatiana R de Moura
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02       Impact factor: 2.743

6.  Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?

Authors:  Rafael Van den Bergh; Jo A Van Ginderachter; Elio Schouppe; Belete A Desimmie; Asrat Hailu; Patrick De Baetselier; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11

7.  In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates.

Authors:  Sarah Hendrickx; Lieselotte Van Bockstal; Guy Caljon; Louis Maes
Journal:  PLoS Negl Trop Dis       Date:  2019-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.